Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Evaluating the safety of new vaccines: summary of a workshop.

Ellenberg SS, Foulkes MA, Midthun K, Goldenthal KL.

Am J Public Health. 2005 May;95(5):800-7.

2.

What should an ideal vaccine postlicensure safety system be?

Griffin MR, Braun MM, Bart KJ.

Am J Public Health. 2009 Oct;99 Suppl 2:S345-50. doi: 10.2105/AJPH.2008.143081.

3.

Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.

Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT.

MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. Erratum in: MMWR Morb Mortal Wkly Rep. 2003 Feb 14;52(06):113.

4.

Enhancing public confidence in vaccines through independent oversight of postlicensure vaccine safety.

Salmon DA, Moulton LH, Halsey NA.

Am J Public Health. 2004 Jun;94(6):947-50.

5.

Statistical, epidemiological, and risk-assessment approaches to evaluating safety of vaccines throughout the life cycle at the Food and Drug Administration.

Ball R, Horne D, Izurieta H, Sutherland A, Walderhaug M, Hsu H.

Pediatrics. 2011 May;127 Suppl 1:S31-8. doi: 10.1542/peds.2010-1722F. Epub 2011 Apr 18. Review.

6.

Evaluating vaccine safety before and after licensure.

Clemens J.

Bull World Health Organ. 2000;78(2):218-9.

7.

Report of a US public health service workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization.

Braun MM, Terracciano G, Salive ME, Blumberg DA, Vermeer-de Bondt PE, Heijbel H, Evans G, Patriarca PA, Ellenberg SS.

Pediatrics. 1998 Nov;102(5):E52.

PMID:
9794982
8.

Challenges in the development, licensure, and use of combination vaccines.

Postema AS, Myers MG, Breiman RF.

Clin Infect Dis. 2001 Dec 15;33 Suppl 4:S261-6.

9.

Current status and future trends in vaccine regulation--USA.

Falk LA, Ball LK.

Vaccine. 2001 Feb 8;19(13-14):1567-72.

PMID:
11166876
10.

Vaccination policies and programs: the federal government's role in making the system work.

Schwartz B, Orenstein WA.

Prim Care. 2001 Dec;28(4):697-711, v.

PMID:
11739026
11.

The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise.

Nguyen M, Ball R, Midthun K, Lieu TA.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:291-7. doi: 10.1002/pds.2323.

PMID:
22262619
12.

Ensuring the optimal safety of licensed vaccines: a perspective of the vaccine research, development, and manufacturing companies.

Kanesa-thasan N, Shaw A, Stoddard JJ, Vernon TM.

Pediatrics. 2011 May;127 Suppl 1:S16-22. doi: 10.1542/peds.2010-1722D. Epub 2011 Apr 18. Review.

13.

Victims of our own success: will immunization remain the paradigm of effective prevention? Grantmakers In Health.

[No authors listed]

Issue Brief (Grantmakers Health). 1999 Aug;(4):1-18.

PMID:
14556299
14.

Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team.

Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Marcy SM, Ward JI, Wise RP, Wassilak SG, Hadler SC.

Pediatrics. 1997 Jun;99(6):765-73.

PMID:
9164767
15.

Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.

Lieberman R, Nelson WG, Sakr WA, Meyskens FL Jr, Klein EA, Wilding G, Partin AW, Lee JJ, Lippman SM.

Urology. 2001 Apr;57(4 Suppl 1):4-27.

PMID:
11295590
16.

Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee.

Peter G, des Vignes-Kendrick M, Eickhoff TC, Fine A, Galvin V, Levine MM, Maldonado YA, Marcuse EK, Monath TP, Osborn JE, Plotkin S, Poland GA, Quinlisk MP, Smith DR, Sokol M, Soland DB, Whitley-Williams PN, Williamson DE, Breiman RF.

Pediatrics. 1999 Oct;104(4 Pt 1):942-50. Review.

PMID:
10506239
18.

Combination vaccines.

Decker MD.

Prim Care. 2001 Dec;28(4):739-61, vi. Review.

PMID:
11739028
19.
20.

Propelling novel vaccines directed against tuberculosis through the regulatory process.

Brennan MJ, Collins FM, Morris SL.

Tuber Lung Dis. 1999;79(3):145-51. Review.

PMID:
10656113
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk